The PandemicH30 Subclone ofEscherichia coliSequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts

MLA

Kim Riddell, et al. “The PandemicH30 Subclone OfEscherichia ColiSequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.” Clinical Infectious Diseases, vol. 62, Mar. 2016, pp. 1529–36. EBSCOhost, https://doi.org/10.1093/cid/ciw193.

APA

Kim Riddell, James R. Johnson, Ajit P. Limaye, Evgeni V. Sokurenko, Paul Thuras, Delia Scholes, Scott J. Weissman, Veronika Tchesnokova, & Brian D. Johnston. (2016). The PandemicH30 Subclone ofEscherichia coliSequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts. Clinical Infectious Diseases, 62, 1529–1536. https://doi.org/10.1093/cid/ciw193

Chicago

Kim Riddell, James R. Johnson, Ajit P. Limaye, Evgeni V. Sokurenko, Paul Thuras, Delia Scholes, Scott J. Weissman, Veronika Tchesnokova, and Brian D. Johnston. 2016. “The PandemicH30 Subclone OfEscherichia ColiSequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.” Clinical Infectious Diseases 62 (March): 1529–36. doi:10.1093/cid/ciw193.